These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1939515)

  • 21. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty.
    Keenan BS; Richards GE; Ponder SW; Dallas JS; Nagamani M; Smith ER
    J Clin Endocrinol Metab; 1993 Apr; 76(4):996-1001. PubMed ID: 8473416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
    Richmond E; Rogol AD; Basdemir D; Veldhuis OL; Clarke W; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3837-44. PubMed ID: 12161519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment.
    Mandel S; Moreland E; Nichols V; Hanna C; Lafranchi S
    J Clin Endocrinol Metab; 1995 Jan; 80(1):190-4. PubMed ID: 7530256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release.
    Roemmich JN; Clark PA; Lusk M; Friel A; Weltman A; Epstein LH; Rogol AD
    Int J Obes Relat Metab Disord; 2002 May; 26(5):701-9. PubMed ID: 12032756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of luteinizing hormone-releasing hormone analog for central precocious puberty on growth hormone (GH) and GH-binding protein.
    DiMartino-Nardi J; Wu R; Varner R; Wong WL; Saenger P
    J Clin Endocrinol Metab; 1994 Mar; 78(3):664-8. PubMed ID: 8126139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone action in puberty: effects by gender.
    Mauras N; Bishop K; Welch S
    Growth Horm IGF Res; 2007 Dec; 17(6):463-71. PubMed ID: 17566776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females--a general clinical research center-based study.
    Veldhuis JD; Roemmich JN; Rogol AD
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2385-94. PubMed ID: 10902783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding protein for human growth hormone: effects of age and weight.
    Holl RW; Snehotta R; Siegler B; Scherbaum W; Heinze E
    Horm Res; 1991; 35(5):190-7. PubMed ID: 1802822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M
    J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children.
    Garrone S; Radetti G; Sidoti M; Bozzola M; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5455-60. PubMed ID: 12466336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum growth hormone-binding protein is unchanged in adult panhypopituitarism.
    Davila N; Alcañiz J; Salto L; Estrada J; Barcelo B; Baumann G
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1347-50. PubMed ID: 7962328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
    Foster CM; Borondy M; Markovs ME; Hopwood NJ; Kletter GB; Beitins IZ
    Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of growth hormone-binding protein and insulin-like growth factor-I during puberty.
    Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
    Clin Endocrinol (Oxf); 1992 Aug; 37(2):175-80. PubMed ID: 1395068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies.
    Maghnie M; Ambrosini L; Cappa M; Pozzobon G; Ghizzoni L; Ubertini MG; di Iorgi N; Tinelli C; Pilia S; Chiumello G; Lorini R; Loche S
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2900-5. PubMed ID: 16684828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
    Muñoz MT; Barrios V; Pozo J; Argente J
    Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. Genentech Collaborative Group.
    Veldhuis JDP6 ; Blizzard RM; Rogol AD; Martha PM; Kirkland JL; Sherman BM
    J Clin Endocrinol Metab; 1992 Apr; 74(4):766-73. PubMed ID: 1548338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence.
    Löfqvist C; Andersson E; Gelander L; Rosberg S; Hulthen L; Blum WF; Wikland KA
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1420-7. PubMed ID: 15598696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.